

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chondrocyte proliferation (GO:0035988) | 5.97540952 |
| 2 | collagen fibril organization (GO:0030199) | 5.66675576 |
| 3 | sequestering of extracellular ligand from receptor (GO:0035581) | 5.23824860 |
| 4 | cell adhesion mediated by integrin (GO:0033627) | 5.10783346 |
| 5 | protein heterotrimerization (GO:0070208) | 4.85018556 |
| 6 | plasma membrane repair (GO:0001778) | 4.69595593 |
| 7 | wound healing, spreading of epidermal cells (GO:0035313) | 4.67150327 |
| 8 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.62709819 |
| 9 | basement membrane organization (GO:0071711) | 4.52966562 |
| 10 | endodermal cell differentiation (GO:0035987) | 4.49700078 |
| 11 | substrate-dependent cell migration (GO:0006929) | 4.36812691 |
| 12 | membrane raft organization (GO:0031579) | 4.24068025 |
| 13 | axon extension involved in axon guidance (GO:0048846) | 4.15709767 |
| 14 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.15709767 |
| 15 | dermatan sulfate biosynthetic process (GO:0030208) | 4.06888820 |
| 16 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.06812574 |
| 17 | glucocorticoid biosynthetic process (GO:0006704) | 4.04777945 |
| 18 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.02477981 |
| 19 | skin morphogenesis (GO:0043589) | 3.98571872 |
| 20 | extracellular fibril organization (GO:0043206) | 3.86734572 |
| 21 | dermatan sulfate metabolic process (GO:0030205) | 3.75353443 |
| 22 | cardiac myofibril assembly (GO:0055003) | 3.73469996 |
| 23 | endocardial cushion development (GO:0003197) | 3.70328288 |
| 24 | collagen metabolic process (GO:0032963) | 3.70180192 |
| 25 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.59928477 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.58152674 |
| 27 | collagen catabolic process (GO:0030574) | 3.57447366 |
| 28 | epithelial cell-cell adhesion (GO:0090136) | 3.56922584 |
| 29 | bone trabecula formation (GO:0060346) | 3.54932477 |
| 30 | fibril organization (GO:0097435) | 3.53720504 |
| 31 | endothelial cell morphogenesis (GO:0001886) | 3.53324084 |
| 32 | wound healing, spreading of cells (GO:0044319) | 3.47584743 |
| 33 | lymph vessel development (GO:0001945) | 3.47292309 |
| 34 | regulation of metalloenzyme activity (GO:0048552) | 3.45361549 |
| 35 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.44280205 |
| 36 | blood vessel maturation (GO:0001955) | 3.44138290 |
| 37 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.40492561 |
| 38 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.39883151 |
| 39 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.36377367 |
| 40 | lymphangiogenesis (GO:0001946) | 3.33810485 |
| 41 | protein localization to cell surface (GO:0034394) | 3.28710548 |
| 42 | keratan sulfate catabolic process (GO:0042340) | 3.28039773 |
| 43 | cellular response to epinephrine stimulus (GO:0071872) | 3.25464237 |
| 44 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.25391125 |
| 45 | multicellular organismal catabolic process (GO:0044243) | 3.24048491 |
| 46 | glomerular basement membrane development (GO:0032836) | 3.23946484 |
| 47 | regulation of tight junction assembly (GO:2000810) | 3.22785341 |
| 48 | multicellular organismal metabolic process (GO:0044236) | 3.22666926 |
| 49 | stress fiber assembly (GO:0043149) | 3.22175001 |
| 50 | extracellular matrix disassembly (GO:0022617) | 3.20617213 |
| 51 | sarcomere organization (GO:0045214) | 3.20509348 |
| 52 | heart trabecula formation (GO:0060347) | 3.18595162 |
| 53 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.17600471 |
| 54 | apoptotic cell clearance (GO:0043277) | 3.16193342 |
| 55 | glomerular filtration (GO:0003094) | 3.15656953 |
| 56 | low-density lipoprotein particle clearance (GO:0034383) | 3.15395582 |
| 57 | atrial septum morphogenesis (GO:0060413) | 3.14666152 |
| 58 | trabecula formation (GO:0060343) | 3.12130435 |
| 59 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.09566540 |
| 60 | negative regulation of fatty acid transport (GO:2000192) | 3.09114426 |
| 61 | positive regulation of receptor recycling (GO:0001921) | 3.06104130 |
| 62 | barbed-end actin filament capping (GO:0051016) | 3.05646243 |
| 63 | extracellular matrix assembly (GO:0085029) | 3.04549895 |
| 64 | hippo signaling (GO:0035329) | 3.03685940 |
| 65 | glucocorticoid metabolic process (GO:0008211) | 3.03387202 |
| 66 | myofibril assembly (GO:0030239) | 3.02852949 |
| 67 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.02163146 |
| 68 | regulation of macrophage chemotaxis (GO:0010758) | 3.00894723 |
| 69 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.99809090 |
| 70 | atrioventricular valve morphogenesis (GO:0003181) | 2.99193029 |
| 71 | endothelial cell proliferation (GO:0001935) | 2.98739961 |
| 72 | fibroblast migration (GO:0010761) | 2.95698233 |
| 73 | negative regulation of anoikis (GO:2000811) | 2.93736961 |
| 74 | venous blood vessel morphogenesis (GO:0048845) | 2.92032449 |
| 75 | regulation of cholesterol storage (GO:0010885) | 2.90993610 |
| 76 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.89385355 |
| 77 | extracellular regulation of signal transduction (GO:1900115) | 2.88659810 |
| 78 | extracellular negative regulation of signal transduction (GO:1900116) | 2.88659810 |
| 79 | extracellular matrix organization (GO:0030198) | 2.88656336 |
| 80 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.87904320 |
| 81 | extracellular structure organization (GO:0043062) | 2.87477473 |
| 82 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.87432414 |
| 83 | protein localization to endosome (GO:0036010) | 2.86177595 |
| 84 | renal filtration (GO:0097205) | 2.84871046 |
| 85 | positive regulation of osteoblast proliferation (GO:0033690) | 2.83118971 |
| 86 | mammary gland development (GO:0030879) | 2.82885669 |
| 87 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.81334896 |
| 88 | ventricular cardiac muscle cell development (GO:0055015) | 2.78149014 |
| 89 | cell-substrate junction assembly (GO:0007044) | 2.76392593 |
| 90 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.75816360 |
| 91 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.75613782 |
| 92 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.73676330 |
| 93 | actin-myosin filament sliding (GO:0033275) | 2.73187286 |
| 94 | muscle filament sliding (GO:0030049) | 2.73187286 |
| 95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.71057552 |
| 96 | adhesion of symbiont to host (GO:0044406) | 2.69732147 |
| 97 | cell migration involved in heart development (GO:0060973) | 2.68433816 |
| 98 | peptidyl-proline hydroxylation (GO:0019511) | 2.67995632 |
| 99 | cell-matrix adhesion (GO:0007160) | 2.66888779 |
| 100 | actomyosin structure organization (GO:0031032) | 2.66544862 |
| 101 | regulation of apoptotic cell clearance (GO:2000425) | 2.66498034 |
| 102 | mesodermal cell differentiation (GO:0048333) | 2.66225507 |
| 103 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.64664134 |
| 104 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.64125199 |
| 105 | cell-substrate adhesion (GO:0031589) | 2.64114863 |
| 106 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.63738496 |
| 107 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.63040594 |
| 108 | endothelium development (GO:0003158) | 2.62399987 |
| 109 | adherens junction assembly (GO:0034333) | 2.62172072 |
| 110 | actin-mediated cell contraction (GO:0070252) | 2.61947170 |
| 111 | response to epinephrine (GO:0071871) | 2.61905250 |
| 112 | sprouting angiogenesis (GO:0002040) | 2.61139844 |
| 113 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.60946948 |
| 114 | positive regulation of macrophage cytokine production (GO:0060907) | 2.58944780 |
| 115 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.58370574 |
| 116 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.58363600 |
| 117 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.56598770 |
| 118 | regulation of macrophage cytokine production (GO:0010935) | 2.56541604 |
| 119 | regulation of mononuclear cell migration (GO:0071675) | 2.54567687 |
| 120 | phagocytosis, recognition (GO:0006910) | 2.46023602 |
| 121 | positive regulation of extracellular matrix organization (GO:1903055) | 2.45612481 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.45078947 |
| 123 | positive regulation of cholesterol efflux (GO:0010875) | 2.41423461 |
| 124 | angiogenesis involved in wound healing (GO:0060055) | 2.38897099 |
| 125 | detection of external biotic stimulus (GO:0098581) | 2.38174000 |
| 126 | pinocytosis (GO:0006907) | 2.32096818 |
| 127 | adhesion of symbiont to host cell (GO:0044650) | 2.30160981 |
| 128 | virion attachment to host cell (GO:0019062) | 2.30160981 |
| 129 | peptide catabolic process (GO:0043171) | 2.29779824 |
| 130 | glycosphingolipid catabolic process (GO:0046479) | 2.29209660 |
| 131 | ovulation from ovarian follicle (GO:0001542) | 2.28024535 |
| 132 | response to peptidoglycan (GO:0032494) | 2.23828965 |
| 133 | cortical actin cytoskeleton organization (GO:0030866) | 2.23568838 |
| 134 | hyaluronan catabolic process (GO:0030214) | 2.23173146 |
| 135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.22552857 |
| 136 | progesterone metabolic process (GO:0042448) | 2.22098943 |
| 137 | negative regulation of platelet activation (GO:0010544) | 2.21956307 |
| 138 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.21556347 |
| 139 | iron ion import (GO:0097286) | 2.21549839 |
| 140 | oligosaccharide catabolic process (GO:0009313) | 2.20537353 |
| 141 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.19994940 |
| 142 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.19096080 |
| 143 | negative regulation of adherens junction organization (GO:1903392) | 2.18245791 |
| 144 | negative regulation of focal adhesion assembly (GO:0051895) | 2.18245791 |
| 145 | negative regulation of cell junction assembly (GO:1901889) | 2.18245791 |
| 146 | import into cell (GO:0098657) | 2.17381878 |
| 147 | cellular response to antibiotic (GO:0071236) | 2.16915014 |
| 148 | positive regulation of cholesterol transport (GO:0032376) | 2.16355106 |
| 149 | positive regulation of sterol transport (GO:0032373) | 2.16355106 |
| 150 | negative regulation of interleukin-12 production (GO:0032695) | 2.15885751 |
| 151 | response to laminar fluid shear stress (GO:0034616) | 2.14489771 |
| 152 | cellular extravasation (GO:0045123) | 2.13176092 |
| 153 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.12861326 |
| 154 | mannose metabolic process (GO:0006013) | 2.12502153 |
| 155 | regulation of extracellular matrix disassembly (GO:0010715) | 2.10908490 |
| 156 | complement activation, alternative pathway (GO:0006957) | 2.08626674 |
| 157 | detection of biotic stimulus (GO:0009595) | 2.07291191 |
| 158 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.06155607 |
| 159 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.05627103 |
| 160 | phagocytosis, engulfment (GO:0006911) | 2.05600095 |
| 161 | chondroitin sulfate catabolic process (GO:0030207) | 2.05551679 |
| 162 | C21-steroid hormone metabolic process (GO:0008207) | 2.05375748 |
| 163 | positive regulation of phagocytosis (GO:0050766) | 2.04577445 |
| 164 | response to thyroid hormone (GO:0097066) | 2.03662446 |
| 165 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.03569785 |
| 166 | positive regulation by symbiont of host defense response (GO:0052509) | 2.03156785 |
| 167 | modulation by symbiont of host defense response (GO:0052031) | 2.03156785 |
| 168 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.03156785 |
| 169 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.03156785 |
| 170 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.03156785 |
| 171 | modulation by symbiont of host immune response (GO:0052553) | 2.03156785 |
| 172 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.02692744 |
| 173 | glycolipid catabolic process (GO:0019377) | 2.02622383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 7.27803355 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.47497176 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.27745927 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.46889579 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.06993302 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.06270585 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.00427344 |
| 8 | CJUN_26792858_Chip-Seq_BT549_Human | 2.98914085 |
| 9 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.96876726 |
| 10 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.77223579 |
| 11 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.70365942 |
| 12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.63165377 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62010247 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.60010847 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.59127886 |
| 16 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.57315414 |
| 17 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.50502256 |
| 18 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.45554363 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.43906915 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.40910396 |
| 21 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.34895383 |
| 22 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.34895383 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.26738550 |
| 24 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.26334181 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.24186262 |
| 26 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.08806607 |
| 27 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.08806607 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.05914192 |
| 29 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.02912542 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00368031 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.00345622 |
| 32 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.97503325 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.96844297 |
| 34 | TP53_16413492_ChIP-PET_HCT116_Human | 1.91140374 |
| 35 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.91019465 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89703761 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83987502 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82519502 |
| 39 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.74268536 |
| 40 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72220636 |
| 41 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72181485 |
| 42 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69767626 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66152748 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65528498 |
| 45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.62667994 |
| 46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.62667994 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55936199 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52761860 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49807368 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49635407 |
| 51 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.47621810 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.47140111 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46304458 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.45273802 |
| 55 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.39691111 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37994500 |
| 57 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.37146919 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36526463 |
| 59 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36258801 |
| 60 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.35860146 |
| 61 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.35688751 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32646875 |
| 63 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32626464 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29151483 |
| 65 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.29135014 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27913740 |
| 67 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.25936484 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24957501 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23920246 |
| 70 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.23481757 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22683835 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22336035 |
| 73 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.22103870 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22018197 |
| 75 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.21865708 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20718662 |
| 77 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20558942 |
| 78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.18569573 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.18270855 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17795377 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17630248 |
| 82 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.16219482 |
| 83 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.15420462 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15354174 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11412749 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11280046 |
| 87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11146796 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10950271 |
| 89 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08662140 |
| 90 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08662140 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08256114 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07977477 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07705075 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07238879 |
| 95 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.05905755 |
| 96 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04124142 |
| 97 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.03375327 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03326737 |
| 99 | * NFI_21473784_ChIP-Seq_ESCs_Mouse | 1.03306755 |
| 100 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01900902 |
| 101 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.99644152 |
| 102 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99505748 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99276207 |
| 104 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.98890081 |
| 105 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.98752554 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98628345 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98344335 |
| 108 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98340521 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98051025 |
| 110 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.97984008 |
| 111 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97717518 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97099914 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95871489 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95389093 |
| 115 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95252339 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95034122 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93949260 |
| 118 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93280458 |
| 119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.92179928 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91881601 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90725121 |
| 122 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90559249 |
| 123 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90171005 |
| 124 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.87909839 |
| 125 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.87593376 |
| 126 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87529202 |
| 127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87321316 |
| 128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.87310798 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87109066 |
| 130 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.86998137 |
| 131 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86362875 |
| 132 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.84490966 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84471377 |
| 134 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.84353328 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84232083 |
| 136 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83976740 |
| 137 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83775652 |
| 138 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83540655 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83402998 |
| 140 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83009656 |
| 141 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82603925 |
| 142 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82556817 |
| 143 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82373448 |
| 144 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.80029142 |
| 145 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79518024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.40680709 |
| 2 | MP0005275_abnormal_skin_tensile | 4.49835811 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.43632817 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.39827584 |
| 5 | MP0004272_abnormal_basement_membrane | 3.73707576 |
| 6 | MP0003279_aneurysm | 3.45934969 |
| 7 | MP0003724_increased_susceptibility_to | 3.15457512 |
| 8 | MP0003950_abnormal_plasma_membrane | 3.10255478 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.03490078 |
| 10 | MP0001958_emphysema | 2.98275695 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.77585577 |
| 12 | MP0008004_abnormal_stomach_pH | 2.76336151 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.74751429 |
| 14 | MP0005623_abnormal_meninges_morphology | 2.70475948 |
| 15 | MP0003303_peritoneal_inflammation | 2.48099495 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.38636592 |
| 17 | MP0003828_pulmonary_edema | 2.38442415 |
| 18 | MP0005171_absent_coat_pigmentation | 2.15232679 |
| 19 | MP0001879_abnormal_lymphatic_vessel | 2.13684713 |
| 20 | MP0009384_cardiac_valve_regurgitation | 2.10390619 |
| 21 | MP0003045_fibrosis | 2.06255759 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.03383543 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.96046328 |
| 24 | MP0009840_abnormal_foam_cell | 1.88776108 |
| 25 | MP0003690_abnormal_glial_cell | 1.83101881 |
| 26 | MP0003091_abnormal_cell_migration | 1.81593879 |
| 27 | MP0000767_abnormal_smooth_muscle | 1.78477346 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.77700950 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.74928055 |
| 30 | MP0005508_abnormal_skeleton_morphology | 1.74792686 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.73383450 |
| 32 | MP0006054_spinal_hemorrhage | 1.72475898 |
| 33 | MP0000751_myopathy | 1.71050662 |
| 34 | MP0003075_altered_response_to | 1.69338763 |
| 35 | MP0001542_abnormal_bone_strength | 1.67902739 |
| 36 | MP0000604_amyloidosis | 1.67547124 |
| 37 | MP0006082_CNS_inflammation | 1.66328255 |
| 38 | MP0005330_cardiomyopathy | 1.61244213 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.59610880 |
| 40 | MP0005023_abnormal_wound_healing | 1.59033878 |
| 41 | MP0006138_congestive_heart_failure | 1.57609048 |
| 42 | MP0000749_muscle_degeneration | 1.52961451 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.48326827 |
| 44 | MP0002108_abnormal_muscle_morphology | 1.48163294 |
| 45 | MP0002060_abnormal_skin_morphology | 1.46702859 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.43395162 |
| 47 | MP0003385_abnormal_body_wall | 1.42066650 |
| 48 | MP0003436_decreased_susceptibility_to | 1.41443167 |
| 49 | MP0000733_abnormal_muscle_development | 1.34082280 |
| 50 | MP0004858_abnormal_nervous_system | 1.31753302 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.29013502 |
| 52 | MP0002419_abnormal_innate_immunity | 1.27328430 |
| 53 | MP0009250_abnormal_appendicular_skeleto | 1.24294543 |
| 54 | MP0003329_amyloid_beta_deposits | 1.23913016 |
| 55 | MP0002972_abnormal_cardiac_muscle | 1.23735800 |
| 56 | MP0004087_abnormal_muscle_fiber | 1.20540151 |
| 57 | MP0002168_other_aberrant_phenotype | 1.20402177 |
| 58 | MP0004510_myositis | 1.20318474 |
| 59 | MP0001544_abnormal_cardiovascular_syste | 1.20010941 |
| 60 | MP0005385_cardiovascular_system_phenoty | 1.20010941 |
| 61 | MP0003941_abnormal_skin_development | 1.18976470 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.17255815 |
| 63 | MP0005409_darkened_coat_color | 1.13719792 |
| 64 | MP0010630_abnormal_cardiac_muscle | 1.12529823 |
| 65 | MP0005595_abnormal_vascular_smooth | 1.10645582 |
| 66 | MP0008775_abnormal_heart_ventricle | 1.10197908 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.09955454 |
| 68 | MP0005620_abnormal_muscle_contractility | 1.08033933 |
| 69 | MP0005390_skeleton_phenotype | 1.07387734 |
| 70 | MP0003567_abnormal_fetal_cardiomyocyte | 1.04335258 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 1.03979206 |
| 72 | MP0000920_abnormal_myelination | 1.03972972 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.03070062 |
| 74 | MP0002128_abnormal_blood_circulation | 1.02826352 |
| 75 | MP0001243_abnormal_dermal_layer | 1.01249307 |
| 76 | MP0000343_altered_response_to | 0.99559472 |
| 77 | MP0010030_abnormal_orbit_morphology | 0.98854290 |
| 78 | MP0002133_abnormal_respiratory_system | 0.97239721 |
| 79 | MP0005388_respiratory_system_phenotype | 0.97239721 |
| 80 | MP0004036_abnormal_muscle_relaxation | 0.96894069 |
| 81 | MP0005166_decreased_susceptibility_to | 0.96250033 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 0.94181221 |
| 83 | MP0001614_abnormal_blood_vessel | 0.93702615 |
| 84 | MP0002332_abnormal_exercise_endurance | 0.91722273 |
| 85 | MP0004130_abnormal_muscle_cell | 0.91560207 |
| 86 | MP0004883_abnormal_blood_vessel | 0.90364246 |
| 87 | MP0002925_abnormal_cardiovascular_devel | 0.87471212 |
| 88 | MP0001851_eye_inflammation | 0.86354942 |
| 89 | MP0005164_abnormal_response_to | 0.85914301 |
| 90 | MP0005165_increased_susceptibility_to | 0.84724370 |
| 91 | MP0001849_ear_inflammation | 0.84619677 |
| 92 | MP0004484_altered_response_of | 0.84352424 |
| 93 | MP0000759_abnormal_skeletal_muscle | 0.83824021 |
| 94 | MP0005369_muscle_phenotype | 0.83123689 |
| 95 | MP0002933_joint_inflammation | 0.83065386 |
| 96 | MP0000747_muscle_weakness | 0.83047407 |
| 97 | MP0005464_abnormal_platelet_physiology | 0.82494683 |
| 98 | MP0003448_altered_tumor_morphology | 0.81876708 |
| 99 | MP0009053_abnormal_anal_canal | 0.81295874 |
| 100 | MP0003795_abnormal_bone_structure | 0.80629684 |
| 101 | MP0008260_abnormal_autophagy | 0.79737801 |
| 102 | MP0009785_altered_susceptibility_to | 0.79017088 |
| 103 | MP0000266_abnormal_heart_morphology | 0.78970113 |
| 104 | MP0003634_abnormal_glial_cell | 0.78546747 |
| 105 | MP0000163_abnormal_cartilage_morphology | 0.76664305 |
| 106 | MP0003115_abnormal_respiratory_system | 0.76244384 |
| 107 | MP0005451_abnormal_body_composition | 0.76121567 |
| 108 | MP0001915_intracranial_hemorrhage | 0.75516950 |
| 109 | MP0001175_abnormal_lung_morphology | 0.75214959 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.74733286 |
| 111 | MP0001299_abnormal_eye_distance/ | 0.74243258 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.74212373 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 0.74151724 |
| 114 | MP0002113_abnormal_skeleton_development | 0.73722779 |
| 115 | MP0002115_abnormal_skeleton_extremities | 0.73206924 |
| 116 | MP0000858_altered_metastatic_potential | 0.73054605 |
| 117 | MP0002106_abnormal_muscle_physiology | 0.71188245 |
| 118 | MP0000428_abnormal_craniofacial_morphol | 0.71043753 |
| 119 | MP0002282_abnormal_trachea_morphology | 0.70776236 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.69048797 |
| 121 | MP0005025_abnormal_response_to | 0.68763218 |
| 122 | MP0002971_abnormal_brown_adipose | 0.68582112 |
| 123 | MP0004233_abnormal_muscle_weight | 0.68271122 |
| 124 | MP0005197_abnormal_uvea_morphology | 0.66994209 |
| 125 | MP0005387_immune_system_phenotype | 0.66932501 |
| 126 | MP0001790_abnormal_immune_system | 0.66932501 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.66682053 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.66551512 |
| 129 | MP0005670_abnormal_white_adipose | 0.66458537 |
| 130 | MP0003935_abnormal_craniofacial_develop | 0.65674772 |
| 131 | MP0003868_abnormal_feces_composition | 0.65356173 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.63568852 |
| 133 | MP0004134_abnormal_chest_morphology | 0.63050086 |
| 134 | MP0005000_abnormal_immune_tolerance | 0.62969953 |
| 135 | MP0003755_abnormal_palate_morphology | 0.61880661 |
| 136 | MP0000516_abnormal_urinary_system | 0.61661515 |
| 137 | MP0005367_renal/urinary_system_phenotyp | 0.61661515 |
| 138 | MP0002127_abnormal_cardiovascular_syste | 0.59465288 |
| 139 | MP0000372_irregular_coat_pigmentation | 0.58048731 |
| 140 | MP0000249_abnormal_blood_vessel | 0.58027293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 8.00193455 |
| 2 | Protrusio acetabuli (HP:0003179) | 7.79136713 |
| 3 | Aortic dissection (HP:0002647) | 5.03172931 |
| 4 | Cerebral aneurysm (HP:0004944) | 4.58543353 |
| 5 | Soft skin (HP:0000977) | 4.53391460 |
| 6 | Atrophic scars (HP:0001075) | 4.42119755 |
| 7 | Aortic aneurysm (HP:0004942) | 4.36031416 |
| 8 | Ankle contracture (HP:0006466) | 4.12854407 |
| 9 | Shallow orbits (HP:0000586) | 4.12806564 |
| 10 | Fragile skin (HP:0001030) | 4.05513409 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.98687880 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.98687880 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.98687880 |
| 14 | Bladder diverticulum (HP:0000015) | 3.91042659 |
| 15 | Dilatation of the ascending aorta (HP:0005111) | 3.83380785 |
| 16 | Broad metatarsal (HP:0001783) | 3.75218651 |
| 17 | Increased connective tissue (HP:0009025) | 3.65596728 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.63215881 |
| 19 | Spinal rigidity (HP:0003306) | 3.60328755 |
| 20 | Peritonitis (HP:0002586) | 3.53407062 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.45569583 |
| 22 | Cervical subluxation (HP:0003308) | 3.42826535 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.42207865 |
| 24 | Abnormality of dentin (HP:0010299) | 3.37358918 |
| 25 | Complement deficiency (HP:0004431) | 3.36536895 |
| 26 | Vertebral compression fractures (HP:0002953) | 3.16604529 |
| 27 | Wormian bones (HP:0002645) | 3.14735239 |
| 28 | Blue sclerae (HP:0000592) | 3.13483748 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.13139300 |
| 30 | Genu recurvatum (HP:0002816) | 3.11299873 |
| 31 | Wrist flexion contracture (HP:0001239) | 3.08585268 |
| 32 | Mitral valve prolapse (HP:0001634) | 3.04475557 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04056319 |
| 34 | Mucopolysacchariduria (HP:0008155) | 3.04056319 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 2.97940568 |
| 36 | Abnormality of complement system (HP:0005339) | 2.94381901 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92998378 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92998378 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92998378 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87413596 |
| 41 | Neonatal short-limb short stature (HP:0008921) | 2.80266961 |
| 42 | Lipoatrophy (HP:0100578) | 2.80143203 |
| 43 | Vascular tortuosity (HP:0004948) | 2.80083489 |
| 44 | Biconcave vertebral bodies (HP:0004586) | 2.79950741 |
| 45 | Follicular hyperkeratosis (HP:0007502) | 2.75605361 |
| 46 | Camptodactyly of toe (HP:0001836) | 2.75163853 |
| 47 | Glomerulonephritis (HP:0000099) | 2.73718224 |
| 48 | Overgrowth (HP:0001548) | 2.72170869 |
| 49 | Myocardial infarction (HP:0001658) | 2.68477681 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.64749580 |
| 51 | Aneurysm (HP:0002617) | 2.57516557 |
| 52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57136665 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.57136665 |
| 54 | Mitral stenosis (HP:0001718) | 2.53863857 |
| 55 | Ulnar claw (HP:0001178) | 2.49740656 |
| 56 | Hyperextensible skin (HP:0000974) | 2.49669765 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.47469104 |
| 58 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.46642561 |
| 59 | Abnormal delivery (HP:0001787) | 2.45221025 |
| 60 | Mitral regurgitation (HP:0001653) | 2.44889678 |
| 61 | Muscle fiber splitting (HP:0003555) | 2.44631289 |
| 62 | Bowel diverticulosis (HP:0005222) | 2.40462334 |
| 63 | Syringomyelia (HP:0003396) | 2.40397021 |
| 64 | Spinal cord lesions (HP:0100561) | 2.40397021 |
| 65 | Esophageal varix (HP:0002040) | 2.40210851 |
| 66 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.35140298 |
| 67 | Pulmonary artery stenosis (HP:0004415) | 2.33126547 |
| 68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.32717592 |
| 69 | Sudden death (HP:0001699) | 2.32293682 |
| 70 | Amyloidosis (HP:0011034) | 2.31393877 |
| 71 | Short nail (HP:0001799) | 2.30839495 |
| 72 | Ovoid vertebral bodies (HP:0003300) | 2.30420457 |
| 73 | Polycythemia (HP:0001901) | 2.28818368 |
| 74 | Increased variability in muscle fiber diameter (HP:0003557) | 2.28087332 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.25565802 |
| 76 | Atrial fibrillation (HP:0005110) | 2.25318942 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.23522819 |
| 78 | Joint laxity (HP:0001388) | 2.23261750 |
| 79 | Right ventricular cardiomyopathy (HP:0011663) | 2.22999309 |
| 80 | Round ear (HP:0100830) | 2.20826862 |
| 81 | Flexion contracture of toe (HP:0005830) | 2.20665830 |
| 82 | Joint contractures involving the joints of the feet (HP:0100492) | 2.20665830 |
| 83 | Abnormality of the acetabulum (HP:0003170) | 2.20185328 |
| 84 | Abnormality of macrophages (HP:0004311) | 2.17619178 |
| 85 | Difficulty climbing stairs (HP:0003551) | 2.15992494 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 2.13937939 |
| 87 | Scapular winging (HP:0003691) | 2.13904958 |
| 88 | Glucose intolerance (HP:0000833) | 2.13753568 |
| 89 | Striae distensae (HP:0001065) | 2.11424013 |
| 90 | Thin bony cortex (HP:0002753) | 2.10846070 |
| 91 | Primary atrial arrhythmia (HP:0001692) | 2.10778725 |
| 92 | Increased density of long bones (HP:0006392) | 2.10312261 |
| 93 | Joint stiffness (HP:0001387) | 2.08858475 |
| 94 | Supraventricular arrhythmia (HP:0005115) | 2.07473963 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 2.07249763 |
| 96 | Skin nodule (HP:0200036) | 2.05774344 |
| 97 | Broad ribs (HP:0000885) | 2.05329744 |
| 98 | Hypoplasia of the iris (HP:0007676) | 2.05128103 |
| 99 | Wide anterior fontanel (HP:0000260) | 2.04432060 |
| 100 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.04202499 |
| 101 | Spondylolisthesis (HP:0003302) | 2.02300268 |
| 102 | Venous abnormality (HP:0002624) | 2.02057312 |
| 103 | Subacute progressive viral hepatitis (HP:0006572) | 2.01680727 |
| 104 | Flared iliac wings (HP:0002869) | 2.01457901 |
| 105 | Ventricular tachycardia (HP:0004756) | 2.01056233 |
| 106 | Abnormality of the calf musculature (HP:0001430) | 1.98960954 |
| 107 | Loss of speech (HP:0002371) | 1.97875970 |
| 108 | Elbow flexion contracture (HP:0002987) | 1.97345851 |
| 109 | Supraventricular tachycardia (HP:0004755) | 1.95913223 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93994023 |
| 111 | Nephritis (HP:0000123) | 1.93312024 |
| 112 | Upper limb muscle weakness (HP:0003484) | 1.91179417 |
| 113 | Axonal loss (HP:0003447) | 1.91161933 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 1.91132431 |
| 115 | Mesomelia (HP:0003027) | 1.90761206 |
| 116 | Distal lower limb muscle weakness (HP:0009053) | 1.90583197 |
| 117 | Hyporeflexia of lower limbs (HP:0002600) | 1.89872209 |
| 118 | Asymmetry of the thorax (HP:0001555) | 1.86191790 |
| 119 | Aortic regurgitation (HP:0001659) | 1.86170477 |
| 120 | Venous insufficiency (HP:0005293) | 1.84790339 |
| 121 | Slender build (HP:0001533) | 1.84490071 |
| 122 | Hematochezia (HP:0002573) | 1.84091355 |
| 123 | Abnormality of the anterior chamber (HP:0000593) | 1.83475459 |
| 124 | Arterial tortuosity (HP:0005116) | 1.82769557 |
| 125 | Nuclear cataract (HP:0100018) | 1.81412978 |
| 126 | Nonimmune hydrops fetalis (HP:0001790) | 1.77411519 |
| 127 | Hemorrhage of the eye (HP:0011885) | 1.77207771 |
| 128 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.76856619 |
| 129 | Gingivitis (HP:0000230) | 1.76027142 |
| 130 | Aortic valve stenosis (HP:0001650) | 1.75450090 |
| 131 | Orchitis (HP:0100796) | 1.75409262 |
| 132 | Cupped ribs (HP:0000887) | 1.74979271 |
| 133 | Ectopia lentis (HP:0001083) | 1.71680788 |
| 134 | Breech presentation (HP:0001623) | 1.70998473 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70979985 |
| 136 | Tetraparesis (HP:0002273) | 1.70489131 |
| 137 | Buphthalmos (HP:0000557) | 1.70458527 |
| 138 | Bell-shaped thorax (HP:0001591) | 1.69789907 |
| 139 | Osteopenia (HP:0000938) | 1.69682487 |
| 140 | Pulmonary hypertension (HP:0002092) | 1.69453529 |
| 141 | Delayed cranial suture closure (HP:0000270) | 1.67760694 |
| 142 | Tibial bowing (HP:0002982) | 1.67657767 |
| 143 | Coxa vara (HP:0002812) | 1.67589887 |
| 144 | Muscular dystrophy (HP:0003560) | 1.67547259 |
| 145 | Chondrocalcinosis (HP:0000934) | 1.67058518 |
| 146 | Infantile muscular hypotonia (HP:0008947) | 1.66800530 |
| 147 | Abnormality of the periventricular white matter (HP:0002518) | 1.66515622 |
| 148 | Abnormality of carpal bone ossification (HP:0006257) | 1.65684619 |
| 149 | Increased CSF protein (HP:0002922) | 1.65464978 |
| 150 | Abnormal ossification of hand bones (HP:0005921) | 1.64784266 |
| 151 | Purpura (HP:0000979) | 1.62863191 |
| 152 | Joint hemorrhage (HP:0005261) | 1.60277369 |
| 153 | Visceral angiomatosis (HP:0100761) | 1.59658778 |
| 154 | Myositis (HP:0100614) | 1.58340959 |
| 155 | Recurrent abscess formation (HP:0002722) | 1.56967425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.28292401 |
| 2 | DDR2 | 3.27986083 |
| 3 | TIE1 | 3.25495301 |
| 4 | DMPK | 3.10106713 |
| 5 | LATS1 | 2.72427862 |
| 6 | TRIB3 | 2.53038059 |
| 7 | TRPM7 | 2.49290822 |
| 8 | PDGFRA | 2.45901718 |
| 9 | STK38L | 2.35750994 |
| 10 | MYLK | 2.25448319 |
| 11 | AKT3 | 2.23560691 |
| 12 | EPHB2 | 2.21765210 |
| 13 | NEK9 | 2.19719298 |
| 14 | PKN2 | 2.18608634 |
| 15 | ZAK | 2.18128107 |
| 16 | LATS2 | 2.03032561 |
| 17 | STK24 | 2.00342283 |
| 18 | FER | 2.00019630 |
| 19 | PIK3CA | 1.98441856 |
| 20 | TGFBR2 | 1.93476796 |
| 21 | PTK2B | 1.89239144 |
| 22 | STK3 | 1.88612221 |
| 23 | PAK2 | 1.87053255 |
| 24 | BLK | 1.77062737 |
| 25 | FES | 1.71355992 |
| 26 | LIMK1 | 1.68928531 |
| 27 | PRPF4B | 1.63638398 |
| 28 | TESK1 | 1.60160182 |
| 29 | ERBB3 | 1.54739971 |
| 30 | KDR | 1.54729800 |
| 31 | NUAK1 | 1.52647297 |
| 32 | PAK3 | 1.47756278 |
| 33 | RIPK1 | 1.47635731 |
| 34 | TYK2 | 1.44867451 |
| 35 | PTK2 | 1.43594323 |
| 36 | NME2 | 1.42651510 |
| 37 | PAK4 | 1.42207324 |
| 38 | EPHA3 | 1.41967929 |
| 39 | FRK | 1.39776969 |
| 40 | ICK | 1.31597998 |
| 41 | OBSCN | 1.31316402 |
| 42 | ILK | 1.24421865 |
| 43 | ROCK1 | 1.21499279 |
| 44 | FGFR4 | 1.18598717 |
| 45 | PIM2 | 1.17862755 |
| 46 | PTK6 | 1.14297337 |
| 47 | MAP3K13 | 1.10386004 |
| 48 | BMX | 1.07817850 |
| 49 | TGFBR1 | 1.07081371 |
| 50 | ZAP70 | 1.05262417 |
| 51 | RIPK4 | 1.04776157 |
| 52 | MET | 1.03397983 |
| 53 | TAOK2 | 1.00476280 |
| 54 | PLK2 | 0.97668294 |
| 55 | PIK3CG | 0.97541734 |
| 56 | EPHB1 | 0.96844964 |
| 57 | FGR | 0.93516967 |
| 58 | IRAK3 | 0.92167486 |
| 59 | MAPK12 | 0.90994320 |
| 60 | NTRK1 | 0.90737930 |
| 61 | LRRK2 | 0.90410976 |
| 62 | PDGFRB | 0.89123606 |
| 63 | SGK3 | 0.89010133 |
| 64 | PDPK1 | 0.88098170 |
| 65 | CAMK1G | 0.87251413 |
| 66 | MAPK7 | 0.86956898 |
| 67 | SGK2 | 0.86675896 |
| 68 | CAMKK2 | 0.86625528 |
| 69 | MAP3K3 | 0.86141355 |
| 70 | MAP3K6 | 0.86047394 |
| 71 | RPS6KA4 | 0.85318273 |
| 72 | KSR2 | 0.83182704 |
| 73 | INSR | 0.82280775 |
| 74 | MKNK1 | 0.81725544 |
| 75 | JAK2 | 0.81212407 |
| 76 | MARK2 | 0.81081811 |
| 77 | PRKAA2 | 0.80922452 |
| 78 | JAK3 | 0.78829989 |
| 79 | MST1R | 0.76914312 |
| 80 | RPS6KA2 | 0.75713153 |
| 81 | PDK2 | 0.73886197 |
| 82 | EEF2K | 0.73095846 |
| 83 | CDC42BPA | 0.72902337 |
| 84 | MAP3K1 | 0.72181560 |
| 85 | ERN1 | 0.71207432 |
| 86 | MOS | 0.70843649 |
| 87 | PRKD1 | 0.70593827 |
| 88 | CSF1R | 0.70427741 |
| 89 | FGFR1 | 0.69940700 |
| 90 | SIK1 | 0.66561620 |
| 91 | MAP3K14 | 0.65260669 |
| 92 | TNK2 | 0.64723457 |
| 93 | GRK7 | 0.64183066 |
| 94 | CDK6 | 0.63601919 |
| 95 | MAP2K3 | 0.63271749 |
| 96 | SCYL2 | 0.62855108 |
| 97 | STK10 | 0.62460566 |
| 98 | MARK3 | 0.62286294 |
| 99 | CAMK1D | 0.62235900 |
| 100 | TBK1 | 0.61142574 |
| 101 | MTOR | 0.59691327 |
| 102 | FGFR3 | 0.59514481 |
| 103 | TYRO3 | 0.59248940 |
| 104 | SGK494 | 0.58172420 |
| 105 | SGK223 | 0.58172420 |
| 106 | PDK1 | 0.58159833 |
| 107 | HCK | 0.56724537 |
| 108 | DAPK3 | 0.56470412 |
| 109 | PRKG2 | 0.56203277 |
| 110 | WNK1 | 0.51188437 |
| 111 | ROCK2 | 0.51127329 |
| 112 | NLK | 0.50254330 |
| 113 | MAPKAPK3 | 0.49664193 |
| 114 | LMTK2 | 0.49461201 |
| 115 | MAP3K7 | 0.48094771 |
| 116 | YES1 | 0.47552333 |
| 117 | CSK | 0.47188454 |
| 118 | MELK | 0.46619303 |
| 119 | ABL1 | 0.45518745 |
| 120 | IGF1R | 0.45100214 |
| 121 | JAK1 | 0.44749676 |
| 122 | SRC | 0.44621191 |
| 123 | MAP3K2 | 0.44520792 |
| 124 | RPS6KC1 | 0.43994460 |
| 125 | RPS6KL1 | 0.43994460 |
| 126 | PDK4 | 0.43612818 |
| 127 | PDK3 | 0.43612818 |
| 128 | EPHA2 | 0.43540134 |
| 129 | PRKD3 | 0.42872579 |
| 130 | ARAF | 0.40989099 |
| 131 | MKNK2 | 0.40432013 |
| 132 | PRKCE | 0.40283665 |
| 133 | ABL2 | 0.39193938 |
| 134 | PRKD2 | 0.38082250 |
| 135 | KIT | 0.36141907 |
| 136 | PRKCH | 0.35107810 |
| 137 | EIF2AK2 | 0.35075425 |
| 138 | STK4 | 0.33879120 |
| 139 | RET | 0.33694951 |
| 140 | FLT3 | 0.33351189 |
| 141 | MAP3K5 | 0.32973731 |
| 142 | MAP2K1 | 0.29970144 |
| 143 | IRAK1 | 0.29855954 |
| 144 | PAK1 | 0.29030179 |
| 145 | TEC | 0.26941163 |
| 146 | ADRBK1 | 0.25621359 |
| 147 | MAPKAPK2 | 0.23390315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.18099647 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.39709530 |
| 3 | Focal adhesion_Homo sapiens_hsa04510 | 3.38630105 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.20773469 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.89482792 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.75503691 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67720215 |
| 8 | Viral myocarditis_Homo sapiens_hsa05416 | 2.62378795 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.57421732 |
| 10 | Adherens junction_Homo sapiens_hsa04520 | 2.52978553 |
| 11 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.38962911 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.24794753 |
| 13 | Amoebiasis_Homo sapiens_hsa05146 | 2.22678188 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.19755989 |
| 15 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.15892030 |
| 16 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.12856482 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96851451 |
| 18 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.90648913 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.74893341 |
| 20 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.73974596 |
| 21 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.73258226 |
| 22 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.66150052 |
| 23 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.62448921 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.49416167 |
| 25 | Melanoma_Homo sapiens_hsa05218 | 1.45100042 |
| 26 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.42937595 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.36103773 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.34608568 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.29357968 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.27548644 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27134642 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24171049 |
| 33 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.21287190 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20100705 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17893340 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17864852 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.17461535 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10883180 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09981121 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.08319898 |
| 41 | Pathways in cancer_Homo sapiens_hsa05200 | 1.05485027 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.03581063 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03004107 |
| 44 | Prostate cancer_Homo sapiens_hsa05215 | 0.95064895 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94917273 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.93494785 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90117019 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 0.88387512 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85129788 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83610727 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83022510 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82766360 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81692224 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80898400 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80419843 |
| 56 | Glioma_Homo sapiens_hsa05214 | 0.80145053 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77177816 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.75357202 |
| 59 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.75258560 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74993618 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74755872 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74535568 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73866854 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.72801234 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.72193784 |
| 66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.72115721 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72083340 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71927267 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71735138 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70737482 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70549610 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68330928 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67309518 |
| 74 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.67186792 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66717004 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66082919 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64890066 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.64816346 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64025370 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.63125513 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62759145 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62690213 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62234097 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62209787 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61647519 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60861844 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60707713 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59691318 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.59346164 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58421999 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57366487 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56443955 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.56095379 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55728004 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55622436 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55205277 |
| 97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54747777 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53589483 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53519306 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53476354 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53362908 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53259964 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53051407 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.52149900 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50868814 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.50822431 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.50776185 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50200845 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.49746552 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.49538641 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49368494 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47426332 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46986132 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46156627 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45606809 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45481941 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45203926 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43254330 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42434163 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42405157 |
| 121 | Cell cycle_Homo sapiens_hsa04110 | 0.41418957 |
| 122 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41012621 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40120190 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38177995 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37681020 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37476302 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37192700 |
| 128 | Legionellosis_Homo sapiens_hsa05134 | 0.36588108 |
| 129 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33388021 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33368405 |
| 131 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32391517 |
| 132 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.32355225 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32269784 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30303636 |

